This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voladri, R. K. R.
Right arrow Articles by Kernodle, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voladri, R. K. R.
Right arrow Articles by Kernodle, D. S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 1998, p. 1375-1381, Vol. 42, No. 6
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Recombinant Expression and Characterization of the Major beta -Lactamase of Mycobacterium tuberculosis

Rama Kishan R. Voladri,1 David L. Lakey,1,2 Steven H. Hennigan,1 Barbara E. Menzies,1,3 Kathryn M. Edwards,2 and Douglas S. Kernodle1,3,*

Divisions of Infectious Disease, Department of Medicine,1 and Division of Infectious Diseases, Department of Pediatrics,2 Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2605, and Department of Veterans Affairs Medical Center, Nashville, Tennessee 372123

Received 22 August 1997/Returned for modification 5 December 1997/Accepted 15 March 1997

New antibiotic regimens are needed for the treatment of multidrug-resistant tuberculosis. Mycobacterium tuberculosis has a thick peptidoglycan layer, and the penicillin-binding proteins involved in its biosynthesis are inhibited by clinically relevant concentrations of beta -lactam antibiotics. beta -Lactamase production appears to be the major mechanism by which M. tuberculosis expresses beta -lactam resistance. beta -Lactamases from the broth supernatant of 3- to 4-week-old cultures of M. tuberculosis H37Ra were partially purified by sequential gel filtration chromatography and chromatofocusing. Three peaks of beta -lactamase activity with pI values of 5.1, 4.9, and 4.5, respectively, and which accounted for 10, 78, and 12% of the total postchromatofocusing beta -lactamase activity, respectively, were identified. The beta -lactamases with pI values of 5.1 and 4.9 were kinetically indistinguishable and exhibited predominant penicillinase activity. In contrast, the beta -lactamase with a pI value of 4.5 showed relatively greater cephalosporinase activity. An open reading frame in cosmid Y49 of the DNA library of M. tuberculosis H37Rv with homology to known class A beta -lactamases was amplified from chromosomal DNA of M. tuberculosis H37Ra by PCR and was overexpressed in Escherichia coli. The recombinant enzyme was kinetically similar to the pI 5.1 and 4.9 enzymes purified directly from M. tuberculosis. It exhibited predominant penicillinase activity and was especially active against azlocillin. It was inhibited by clavulanic acid and m-aminophenylboronic acid but not by EDTA. We conclude that the major beta -lactamase of M. tuberculosis is a class A beta -lactamase with predominant penicillinase activity. A second, minor beta -lactamase with relatively greater cephalosporinase activity is also present.


* Corresponding author. A-3310 MCN, Vanderbilt University, 1161 21st Ave. South, Nashville, TN 37212-2605. Phone: (615) 327-4751, ext. 5486. Fax: (615) 343-6160. E-mail: doug.kernodle{at}vanderbilt.edu.


Antimicrobial Agents and Chemotherapy, June 1998, p. 1375-1381, Vol. 42, No. 6
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • McDonough, J. A., McCann, J. R., Tekippe, E. M., Silverman, J. S., Rigel, N. W., Braunstein, M. (2008). Identification of Functional Tat Signal Sequences in Mycobacterium tuberculosis Proteins. J. Bacteriol. 190: 6428-6438 [Abstract] [Full Text]  
  • Wang, F., Cassidy, C., Sacchettini, J. C. (2006). Crystal Structure and Activity Studies of the Mycobacterium tuberculosis {beta}-Lactamase Reveal Its Critical Role in Resistance to {beta}-Lactam Antibiotics.. Antimicrob. Agents Chemother. 50: 2762-2771 [Abstract] [Full Text]  
  • Sauvage, E., Fonze, E., Quinting, B., Galleni, M., Frere, J.-M., Charlier, P. (2006). Crystal Structure of the Mycobacterium fortuitum Class A {beta}-Lactamase: Structural Basis for Broad Substrate Specificity.. Antimicrob. Agents Chemother. 50: 2516-2521 [Abstract] [Full Text]  
  • McDonough, J. A., Hacker, K. E., Flores, A. R., Pavelka, M. S. Jr, Braunstein, M. (2005). The Twin-Arginine Translocation Pathway of Mycobacterium smegmatis Is Functional and Required for the Export of Mycobacterial {beta}-Lactamases. J. Bacteriol. 187: 7667-7679 [Abstract] [Full Text]  
  • Flores, A. R., Parsons, L. M., Pavelka,, M. S. Jr (2005). Genetic analysis of the {beta}-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to {beta}-lactam antibiotics. Microbiology 151: 521-532 [Abstract] [Full Text]  
  • Philalay, J. S., Palermo, C. O., Hauge, K. A., Rustad, T. R., Cangelosi, G. A. (2004). Genes Required for Intrinsic Multidrug Resistance in Mycobacterium avium. Antimicrob. Agents Chemother. 48: 3412-3418 [Abstract] [Full Text]  
  • Goffin, C., Ghuysen, J.-M. (2002). Biochemistry and Comparative Genomics of SxxK Superfamily Acyltransferases Offer a Clue to the Mycobacterial Paradox: Presence of Penicillin-Susceptible Target Proteins versus Lack of Efficiency of Penicillin as Therapeutic Agent. Microbiol. Mol. Biol. Rev. 66: 702-738 [Abstract] [Full Text]  
  • Bebrone, C., Moali, C., Mahy, F., Rival, S., Docquier, J. D., Rossolini, G. M., Fastrez, J., Pratt, R. F., Frère, J.-M., Galleni, M. (2001). CENTA as a Chromogenic Substrate for Studying {beta}-Lactamases. Antimicrob. Agents Chemother. 45: 1868-1871 [Abstract] [Full Text]